WallStreetZenWallStreetZen

NASDAQ: LKFT
Lakefront Biotherapeutics Nv Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Lakefront Biotherapeutics Nv revenue was $1.16B for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $9.3M, down 98.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LKFT annual revenue was $1.3B, with 355.7% growth year-over-year.

LKFT past revenue growth

How has LKFT's revenue growth performed historically?

Company
259.47%
Industry
246.05%
Market
38.36%
LKFT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LKFT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LKFT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LKFT revenue history

Current Revenue
$1.1B
Current Earnings
$561.8M
Current Profit Margin
49.7%

Be the first to know when LKFT announces revenue.

LKFT Revenue History By Year

LKFT Yearly RevenueLKFT RevenueLKFT ChangeLKFT Revenue Growth
2025-12-31$1.31B$1.02B+355.72%
2024-12-31$287.13M$20.77M+7.80%
2023-12-31$266.36M$9.71M+3.78%
2022-12-31$256.65M-$9.70M-3.64%
2021-12-31$266.35M-$316.65M-54.31%
2020-12-31$582.99M-$355.10M-37.85%
2019-12-31$938.09M$584.45M+165.27%
2018-12-31$353.64M$166.46M+88.93%
2017-12-31$187.18M$27.58M+17.28%
2016-12-31$159.59M$93.82M+142.63%
2015-12-31$65.78M-$43.21M-39.65%
2014-12-31$108.98M-$23.85M-17.96%
2013-12-31$132.84M$11.17M+9.18%
2012-12-31$121.67MN/AN/A

1 of 1

Lakefront Biotherapeutics Nv Revenue FAQ

What was LKFT's revenue last quarter?

On Invalid Date, Lakefront Biotherapeutics Nv (NASDAQ: LKFT) reported Q1 2026 revenue of $9.26 million up 93.74% year over year. In the same quarter last year, Lakefront Biotherapeutics Nv's revenue was $148.02 million.

What was Lakefront Biotherapeutics Nv's revenue in 2025?

Lakefront Biotherapeutics Nv's annual revenue for the twelve months ending Dec 31, 2025 was $1.31 billion, a 355.72% increase year over year.

How much does Lakefront Biotherapeutics Nv make in a day?

Based on Lakefront Biotherapeutics Nv annual revenue for the past five years, LKFT makes an average of $1,306,857.40 per day.

What was Lakefront Biotherapeutics Nv's annual revenue growth in the past year?

As of Q2 2026, Lakefront Biotherapeutics Nv's revenue has grown 259.47% year over year. This is 13.42 percentage points higher than the US Biotechnology industry revenue growth rate of 246.05%. Lakefront Biotherapeutics Nv's revenue in the past year totaled $1.16 billion.

How much does Lakefront Biotherapeutics Nv make in a year?

Lakefront Biotherapeutics Nv's revenue by year for the past five years is:
  • Lakefront Biotherapeutics Nv's revenue for the twelve months ending Dec 31, 2025 was $1.31 billion, a 355.72% increase year over year.
  • Lakefront Biotherapeutics Nv's annual revenue for Dec 31, 2024 was $287.13 million, a 7.8% increase from 2023.
  • Lakefront Biotherapeutics Nv's annual revenue for 2023 was $266.36 million, a 3.78% increase from 2022.
  • Lakefront Biotherapeutics Nv's annual revenue for 2022 was $256.65 million, a 3.64% decrease from 2021.
  • Lakefront Biotherapeutics Nv's annual revenue for 2021 was $266.35 million, a 54.31% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.